SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-20-326084
Filing Date
2020-12-23
Accepted
2020-12-23 16:42:47
Documents
3
Group Members
ASPIRE CAPITAL PARTNERS, LLCCHRISKO INVESTORS, INC.CHRISTOS KOMISSOPOULOSERIK J. BROWNRED CEDAR CAPITAL CORP.SGM HOLDINGS CORP.STEVEN G. MARTINWILLIAM F. BLANK, IIIWML VENTURES CORP.

Document Format Files

Seq Description Document Type Size
1 SC 13G d103855dsc13g.htm SC 13G 187350
2 EX-99.1 d103855dex991.htm EX-99.1 9498
3 EX-99.2 d103855dex992.htm EX-99.2 13568
  Complete submission text file 0001193125-20-326084.txt   212331
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80136 | Film No.: 201412893
SIC: 2834 Pharmaceutical Preparations

Mailing Address 155 NORTH WACKER DRIVE SUITE 1600 CHICAGO IL 60606
Business Address 155 NORTH WACKER DRIVE SUITE 1600 CHICAGO IL 60606 312.658.0400
Aspire Capital Fund, LLC (Filed by) CIK: 0001535683 (see all company filings)

IRS No.: 271406279
Type: SC 13G